​​Researchers in Singapore have joined hands with their overseas counterparts in the race to discover vaccines or treatments for COVID-19. The Agency for Science, Technology and Research has partnered with Japanese pharmaceutical company Chugai Pharmabody Research to develop an antibody that targets specific areas of COVID-19, preventing it from infecting cells. Duke-NUS Medical School together with United States medicine company Arcturus Therapeutics, is working on a vaccine that gets the human body to produce part of the virus in order to fight it. Home-grown contract development and manufacturing organisation Esco Aster is also collaborating with US biotech company Vivaldi Biosciences to develop a vaccine that protects against Covid-19 and the flu, and can be easily adapted if the coronavirus mutates.

Read the full news article here (infopedia access only).